Skip to Content

IPRATROPIUM BROMIDE 250MCG / 1ML NEBULISER SOLUTION

Active substance(s): IPRATROPIUM BROMIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes
any possible side effects not listed in this leaflet. You can also report side
effects directly via Yellow Card Scheme Website:
www.mhra.gov.uk/yellowcard
By reporting side affects you can help provide more information on the safety
of this medicine.

Marketing Authorisation Holder:
Breath Limited, Whiddon Valley, Barnstaple, North Devon, EX32 8NS,
United Kingdom.
Manufacturing
Laboratoire Unither, Espace Industriel Nord, 151 rue André Durouchez CS 28028, 80084 AMIENS CEDEX 2, France.
This leaflet was last revised in September 2014.

Ipratropium Nebules 250mcg/1ml 500mcg/2ml PIL - UK(Arrow)
item no: AAAH2695

dimensions: 200 x 280

print proof no: 2

pharmacode:

origination date: 24.09.14

min pt size: 8pt

originated by: DR
approved for print/date

colours/plates
1. Black
2.
3.
4.
5.
6.

revision date: 29.09.14

Technical Approval

revised by: DR

date sent: 24.09.14

supplier: Laboratoire Unither

technically app. date: 29.09.14

Non Printing Colours
1. Profile
2.

3.

AAAH2695

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide